Allergan Continues to Grow Medical Aesthetics Franchise with Exicure Deal
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)
Published: 20 Nov-2019
DOI: 10.3833/pdr.v2019.i11.2469 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
While its merger with AbbVie is being finalised, Allergan has partnered with clinical-stage biotech company, Exicure, to develop treatments for hair loss disorders utilising Exicure’s proprietary SNA™ (spherical nucleic acid) technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS